The Oxford-AstraZeneca vaccine is best suited for Africa according to Professor of Vaccinology at the University of the Witwatersrand, Shabir Madhi.
Professor Madhi is leading the clinical trial of the vaccine locally.
He said the vaccine isn’t only effective but also affordable.
The Oxford vaccine is so far reported to have a good safety record with no serious side-effects.
The ongoing late-stage trial is taking place at 150 global sites in the US, Germany, Turkey, South Africa, Brazil and Argentina.
More Stories
Unions Expected To Report Back On Decision On Eskom Wage Offer
Eastern Cape Officials Vow Action Against Non-Compliant Taverns
NICD Reports 109 New COVID-19 Cases In SA
Eskom Warns Recovery Will Take Weeks
Khaya Magadla’s Family Relieved His Body Has Been Found
Install Prepaid Meters Or Stay In The Dark – Eskom To Soweto Residents
Ramaphosa Concerned About Underage Drinking
The Body Of Khaya Magadla Has Been Found
Unions Take Eskom’s Wage Offer To Members
NICD Reports 380 New COVID-19 Cases In SA
Eskom, Union Negotiators Set To Continue
City Of Cape Town Aiming To Make Trains Safer